Range
- - -
Vol / Avg.
-/356.8K
Div / Yield
-
52 Wk
7.68 - 25.03
Mkt Cap
323.6M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.61
Shares
36.9M
Outstanding
36.9M
Total Float
22.4M
Sector: Health Care.Industry: Biotechnology
Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-11
REV
Q1 2021Est.ActualSurprise
EPS-0.680-0.700 -0.0200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
BCELAtreca4.9%323.6M

Atreca Frequently Asked Questions

Q

How do I buy Atreca (BCEL) stock?

A

You can purchase shares of Atreca (NASDAQ: BCEL) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Atreca (BCEL) stock?

A

The latest price target for Atreca (NASDAQ: BCEL) was reported by Jefferies on February 8, 2021. The analyst firm set a price target for 30.00 expecting BCEL to rise to within 12 months (a possible 242.08% upside). 2 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Atreca (BCEL)?

A

The stock price for Atreca (NASDAQ: BCEL) is $8.77 last updated Thu Jun 24 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Atreca (BCEL) pay a dividend?

A

There are no upcoming dividends for Atreca.

Q

When is Atreca (NASDAQ:BCEL) reporting earnings?

A
Atreca’s Q2 earnings are confirmed for after-market on August 11, 2021.
Q

Is Atreca (BCEL) going to split?

A

There is no upcoming split for Atreca.

Q

What sector and industry does Atreca (BCEL) operate in?

A

Atreca is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.